Drug Shortage Report for SANDOZ OLMESARTAN

Last updated on 2024-03-26 History
Report ID 223197
Drug Identification Number 02443414
Brand name SANDOZ OLMESARTAN
Common or Proper name OLMESARTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) OLMESARTAN MEDOXOMIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100FCT
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-03-25
Estimated end date 2024-04-19
Actual end date
Shortage status Actual shortage
Updated date 2024-03-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-03-26 English Compare
v4 2024-03-25 French Compare
v3 2024-03-25 English Compare
v2 2024-03-25 English Compare
v1 2024-03-25 English Compare

Showing 1 to 5 of 5